Tag: Manidipine

According to extensive research, Cardiplot, a brand name for the medication Manidipine, is a third-generation calcium channel blocker primarily used to treat mild to moderate essential hypertension, or high blood pressure. Its ability to effectively reduce blood pressure with a sustained effect can be a valuable tool in managing cardiovascular risk.

Patented in 1982 and approved for medical use in 1990, manidipine is a third-generation dihydropyridine calcium channel blocker primarily used to treat hypertension. This medication is known for its ability to lower blood pressure effectively while offering distinct advantages, including a favorable side-effect profile and unique effects on renal function, making it a nuanced option within its drug class.

According to the National Drug Information database, Cardiplot is a brand name for manidipine hydrochloride, a vital calcium channel blocker primarily used for managing hypertension. It is often prescribed for patients when a lower dose is insufficient for controlling high blood pressure.

Manidipine is a third-generation dihydropyridine calcium channel blocker widely prescribed for the management of high blood pressure. Research has demonstrated its effectiveness in reducing blood pressure, with a particularly favorable side effect profile compared to some older medications in its class, such as a lower incidence of ankle edema.